| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3695707
Max Phase: Preclinical
Molecular Formula: C28H30N4O4S
Molecular Weight: 518.64
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: Cc1ccc(N2CCN(C(=O)C(NS(=O)(=O)c3ccc4c(c3)CCC(=O)N4)c3ccccc3)CC2)cc1
Standard InChI: InChI=1S/C28H30N4O4S/c1-20-7-10-23(11-8-20)31-15-17-32(18-16-31)28(34)27(21-5-3-2-4-6-21)30-37(35,36)24-12-13-25-22(19-24)9-14-26(33)29-25/h2-8,10-13,19,27,30H,9,14-18H2,1H3,(H,29,33)
Standard InChI Key: NWNTVXCJXSIQMG-UHFFFAOYSA-N
Associated Targets(Human)
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit 206 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 518.64 | Molecular Weight (Monoisotopic): 518.1988 | AlogP: 3.25 | #Rotatable Bonds: 6 |
| Polar Surface Area: 98.82 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
| #RO5 Violations: 1 | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: 8.83 | CX Basic pKa: 3.85 | CX LogP: 3.65 | CX LogD: 3.64 |
| Aromatic Rings: 3 | Heavy Atoms: 37 | QED Weighted: 0.52 | Np Likeness Score: -1.54 |
References
| 1. (2015) O-GlcNAc transferase inhibitors and uses thereof, |
Source
Source(1):